DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

InterMune (NASDAQ: ITMN)

73.88 73.88 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ITMN $73.88 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $8.0B
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$2.72




Drug Makers

InterMune (ITMN) Description

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology. Website:

News & Commentary Rss Feed

Up 35% on Buyout: InterMune inc Investor Key Takeaways

FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved.

FibroGen Looks Healthy Heading Into IPO

Mario Gabelli Comments on InterMune Inc

Today In SA PRO: Monday, October 6

Announcing This Week's Outstanding Performance Awards - The GeoTeam And Joe McCann

IWO, ITMN, WEX, PBYI: Large Inflows Detected at ETF

Why Roche (RHHBY) Stock Is Up Today

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

10 Nasdaq stocks with returns of at least 240% in 2014

Is Roche At Risk Of Losing Its Way?

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

Roche's Cobas 6800/8800 Testing Systems Launched - Analyst Blog

See More ITMN News...

ITMN's Top Competitors

ITMN $73.88 (0.00%)
Current stock: ITMN
AMGN $159.60 (0.26%)
Current stock: AMGN
GILD $103.42 (0.34%)
Current stock: GILD
BIIB $425.61 (2.77%)
Current stock: BIIB